Per Soelberg Sørensen

Per Soelberg Sørensen

Professor emeritus, Professor, emeritus

Member of:

  • Neurology


Publication year:
All
41 - 50 out of 256Page size: 10
  1. 2020
  2. Published

    Initial high-efficacy disease-modifying therapy in multiple sclerosis: A nationwide cohort study

    Buron, M. D., Chalmer, T. A., Sellebjerg, Finn Thorup, Barzinji, I., Christensen, J. R., Christensen, M. K., Hansen, V., Illes, Z., Jensen, H. B., Kant, M., Papp, V., Petersen, T., Rasmussen, P. V., Schäfer, J., Theódórsdóttir, Á., Weglewski, Arkadiusz, Sørensen, Per Soelberg & Magyari, M., 2020, In: Neurology. 95, 8, p. e1041-e1051

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Long term effect of delayed treatment on disability in patients with paediatric onset multiple sclerosis: A prospective Danish cohort study

    Kopp, T. I., Blinkenberg, M., Petersen, T., Sørensen, Per Soelberg & Magyari, M., 2020, In: Multiple Sclerosis and Related Disorders. 40, 101956.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Predictors of treatment outcome in patients with paediatric onset multiple sclerosis

    Kopp, T. I., Blinkenberg, M., Chalmer, T. A., Petersen, T., Ravnborg, M. H., Sørensen, Per Soelberg & Magyari, M., 2020, In: Multiple Sclerosis Journal. 26, 8, p. 964-975

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Real-time assessment of COVID-19 prevalence among multiple sclerosis patients: a multicenter European study

    Dalla Costa, G., Leocani, L., Montalban, X., Guerrero, A. I., Sørensen, Per Soelberg, Magyari, M., Dobson, R. J. B., Cummins, N., Narayan, V. A., Hotopf, M., Comi, G. & on behalf of the RADAR-CNS consortium, O. B. O. T. R. C., 2020, In: Neurological Sciences. 41, 7, p. 1647-1650 4 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    The apparently milder course of multiple sclerosis: Changes in the diagnostic criteria, therapy and natural history

    Sørensen, Per Soelberg, Sellebjerg, Finn Thorup, Hartung, H. P., Montalban, X., Comi, G. & Tintoré, M., 2020, In: Brain. 143, 9, p. 2637-2652 16 p.

    Research output: Contribution to journal › Review › Research › peer-review

  7. Published

    The window of opportunity for treatment of progressive multiple sclerosis

    Sørensen, Per Soelberg, Fox, R. J. & Comi, G., 2020, In: Current Opinion in Neurology. 33, 3, p. 262-270

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Using Smartphones and Wearable Devices to Monitor Behavioral Changes During COVID-19

    Sun, S., Folarin, A. A., Ranjan, Y., Rashid, Z., Conde, P., Stewart, C., Cummins, N., Matcham, F., Dalla Costa, G., Simblett, S., Leocani, L., Lamers, F., Sørensen, P. S., Buron, M., Zabalza, A., Guerrero Pérez, A. I., Penninx, B. W., Siddi, S., Haro, J. M., Myin-Germeys, I. & 7 others, Rintala, A., Wykes, T., Narayan, V. A., Comi, G., Hotopf, M., Dobson, R. J. & RADAR-CNS Consortium, R. C., 2020, In: Journal of Medical Internet Research. 22, 9, 19 p., e19992.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. 2019
  10. Published

    Worsening of disability caused by relapses in multiple sclerosis: A different approach

    Koch-Henriksen, N., Thygesen, L. C., Sørensen, Per Soelberg & Magyari, M., Jul 2019, In: Multiple Sclerosis and Related Disorders. 32, p. 1-8

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Efficacy of Cladribine Tablets in high disease activity subgroups of patients with relapsing multiple sclerosis: A post hoc analysis of the CLARITY study

    Giovannoni, G., Sørensen, Per Soelberg, Cook, S., Rammohan, K. W., Rieckmann, P., Comi, G., Dangond, F., Hicking, C. & Vermersch, P., May 2019, In: Multiple Sclerosis Journal. 25, 6, p. 819-827

    Research output: Contribution to journal › Journal article › Research › peer-review

  12. Published

    MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis

    Uccelli, A., Laroni, A., Brundin, L., Clanet, M., Fernandez, O., Nabavi, S. M., Muraro, P. A., Oliveri, R. S., Radue, E. W., Sellner, J., Soelberg Sorensen, P., Sormani, M. P., Wuerfel, J. T., Battaglia, M. A., Freedman, M. S., Bonetti, B., Rush, C., Herrera, C., Ramo Tello, C., Miller, D. & 23 others, Szwajcer, D., Strunk, D., Wall, D., Aguera-Morales, E., Rohde, E., Dazzi, F., Comi, G., Martino, G., Izquierdo Ayuso, G., Rabinovitch, H., MacLean, H., Marriott, J., Racosta, J., Arab, L., Gimona, M., Introna, M., Blinkenberg, M., Aghdami, N., Ali, R., Vosoughi, R., Nicholas, R., Marrie, R. A. & Karimi, S., May 2019, In: Trials. 20, 13 p., 263.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 6 7 8 ...26 Next

ID: 11025